Conjugated Estrogen Cream (Premarin®)
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Postmenopause
Conditions
Postmenopause
Trial Timeline
Sep 1, 2005 → Oct 1, 2006
NCT ID
NCT00484107About Conjugated Estrogen Cream (Premarin®)
Conjugated Estrogen Cream (Premarin®) is a pre-clinical stage product being developed by Pfizer for Postmenopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00484107. Target conditions include Postmenopause.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00484107 | Pre-clinical | Completed |
Competing Products
16 competing products in Postmenopause